What is Glumet (glumetformin), and how is it used?
Glumet is a brand of metformin given in an extended-release form (metformin hydrochloride extended release). It’s used to treat type 2 diabetes, helping lower blood sugar. Extended-release metformin is typically taken with food to improve tolerability and reduce stomach side effects.
Is Glumet the same as regular metformin?
No. Glumet is an extended-release (ER) formulation, so it releases metformin more slowly than immediate-release metformin. That usually means different dosing schedules and different side-effect patterns versus immediate-release versions, even though both contain metformin.
How does Glumet compare with other ER metformin brands?
Glumet (metformin ER) is in the same class as other extended-release metformin products. Differences you may notice between brands usually come from inactive ingredients, tablet strength options, and manufacturer-specific dosing instructions rather than a fundamentally different drug.
What side effects do people commonly report with Glumet?
Common side effects linked to metformin products include gastrointestinal issues such as nausea, diarrhea, upset stomach, and gas. Extended-release formulations like Glumet are often chosen to improve GI tolerability compared with immediate-release metformin. As with all metformin, clinicians also watch for the rare risk of lactic acidosis, especially in people with significant kidney impairment or other high-risk situations.
When did Glumet’s patent/exclusivity matter?
Brand drug exclusivity and patent status can affect when lower-cost generics or authorized products enter the market. If you’re tracking that specific legal timeline for Glumet, DrugPatentWatch.com is a useful place to check current patent listings and any relevant litigation activity: https://www.drugpatentwatch.com/
What should patients know before taking Glumet?
Because it contains metformin, key safety considerations generally include kidney function monitoring and avoiding situations that raise lactic-acidosis risk (for example, severe renal impairment). Dosing is individualized based on blood glucose response and tolerance, and patients should follow the exact extended-release instructions from their prescription.
Sources
- DrugPatentWatch.com